BioCentury
ARTICLE | Clinical News

Curis preclinical data

May 4, 2009 7:00 AM UTC

CU-903 demonstrated strong anti-proliferative effects in breast, colon, melanoma and non-small cell lung cancer (NSCLC) cell lines. CU-903 is a small molecule histone deacetylase (HDAC) and phosphoi...